Article type
Year
Abstract
Background:
The Evidence-Based Health Policy Briefs, the most important way to present evidence to health policymakers and policymakers, is widely used in the WHO and many national health sectors.
Objectives:
We aim to analyze the epidemiology and reporting characteristics of health policy briefs.
Methods:
we searched hand-searched Health System Evidence (HSE) and World Health Organization (WHO) databases before January 31, 2020, included health policy briefs in English and Chinese. We excluded the older version. Two reviewers independently completed data extraction and resolved disagreements by discussions.
Results:
A total of 198 articles were retrieved, 119 policy briefs were included. 70(59%) policy briefs were reported in the last 4 years (2010-2013), with no updates in 2016 to 2017. 42(35%) reported Policy Brief, 28(24%) reported Evidence Brief, 9 (8%) reported Issue Brief in title health policy brief; 50(42%) reported appendixes and 117 (98%) reported references. 77 (65%) clearly reported background; 69 (58%) reported methodologies, 68 (57%) reported funding and 64 (54%) reported conflicts of interest, four of them have conflicts of interest; 116 (97%) reported health problems and 68 (57%) reported potential implementation barriers, 91 (76%) reported policy options were clearly reported.
Conclusions:
The formats and contents of the health policy briefs are very different and the formats of the report on their methodologies are too simple. Different briefs developed by different organizations varied a lot in reporting characteristics. However, few policy briefs reported development process, can learn from clinical practice guidelines for reporting standards and quality evaluation, and provide the reference for brief developers in the future. We will further retrieve the database, update the data and analyze the results.
Patient or healthcare consumer involvement:
none.
The Evidence-Based Health Policy Briefs, the most important way to present evidence to health policymakers and policymakers, is widely used in the WHO and many national health sectors.
Objectives:
We aim to analyze the epidemiology and reporting characteristics of health policy briefs.
Methods:
we searched hand-searched Health System Evidence (HSE) and World Health Organization (WHO) databases before January 31, 2020, included health policy briefs in English and Chinese. We excluded the older version. Two reviewers independently completed data extraction and resolved disagreements by discussions.
Results:
A total of 198 articles were retrieved, 119 policy briefs were included. 70(59%) policy briefs were reported in the last 4 years (2010-2013), with no updates in 2016 to 2017. 42(35%) reported Policy Brief, 28(24%) reported Evidence Brief, 9 (8%) reported Issue Brief in title health policy brief; 50(42%) reported appendixes and 117 (98%) reported references. 77 (65%) clearly reported background; 69 (58%) reported methodologies, 68 (57%) reported funding and 64 (54%) reported conflicts of interest, four of them have conflicts of interest; 116 (97%) reported health problems and 68 (57%) reported potential implementation barriers, 91 (76%) reported policy options were clearly reported.
Conclusions:
The formats and contents of the health policy briefs are very different and the formats of the report on their methodologies are too simple. Different briefs developed by different organizations varied a lot in reporting characteristics. However, few policy briefs reported development process, can learn from clinical practice guidelines for reporting standards and quality evaluation, and provide the reference for brief developers in the future. We will further retrieve the database, update the data and analyze the results.
Patient or healthcare consumer involvement:
none.